| 26.97 Real-Time Quote |  +0.02 / +0.07%Today’s Change | 15.24 Today|||52-Week Range 31.63 | +4.01% Year-to-Date |
| Previous close | 26.95 |
| Today’s open | 26.97 |
| Day’s range | 26.85 - 27.30 |
| Volume | 83,321 |
| Average volume (3 months) | 522,895 |
| Market cap | $3.1B |
| Dividend yield | -- |
| Earnings growth (last year) | +402.86% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +34.68% |
| P/E ratio | -- |
| Price/Sales | 9.02 |
| Price/Book | 12.83 |
| Today’s change | Today’s % change | |
|---|---|---|
| AEGRAegerion Pharmaceuti... | -0.54 | -0.88% |
| IMGNImmunogen Inc | +0.27 | +1.66% |
| GEVASynageva Biopharma C... | +0.14 | +0.35% |
| HALOHalozyme Therapeutic... | -0.13 | -1.63% |
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | $0.30 |
| Annual revenue (last year) | $3.4B |
| Annual profit (last year) | $331.6M |
| Net profit margin | 9.79% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Víctor Grifols Roura |
Vice President-Administration & Finance Alfredo Arroyo Guerra |
Corporate headquarters Barcelona, Catalonia |
.
